ACTRN12621001457831尚未招募未知
Screening In First Responders Trial (SIFT): A cluster randomised controlled trial evaluating the effects of workplace mental health screening with feedback tailored to current symptom levels versus screening without tailored feedback on help-seeking behaviours in first responders.
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 1,670
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Inclusion criteria for participants taking part in this study includes:
- •1. Age 18 years or older.
- •2. Currently working as a firefighter or rescue personnel and employed by partnering organisation (Fire & Rescue New South Wales).
- •3. Currently residing in Australia.
排除标准
- •No formal exclusion criteria apply to this study. Only eligible participants will be invited and allowed to participate.
研究者
相似试验
撤回
不适用
Phase I and IIa Trial for Assessment of Safety, Immunogenicity (Phase Ia) and Efficacy (Phase IIa) Against Sporozoite Challenge of P. Falciparum Pre-Erythrocytic and Blood Stage (PfPEBS-LSP) Malaria Vaccine CandidatePlasmodium falciparum10037072MalariaNL-OMON37083Vac4All36
已完成
1 期
A Trial in Healthy Participants to Evaluate the Pharmacokinetics, Safety, Tolerability and Food Effects of Multiple Forms of PRAX-114.DepressionACTRN12620000522910Praxis Precision Medicines Australia, Pty Ltd85
已完成
不适用
Phase I and IIa trial for assessment of safety, immunogenicity and efficacy against sporozoite challenge of the candidate malaria vaccine PfLSA-3-rec.malariaNL-OMON30669Institut Pasteur36
已完成
不适用
A preliminary test to examine the efficacy and safety of web-based brief intervention (ALMIGHT brief) for high-risk drinkersJPRN-UMIN000040666CureApp, Inc.15
进行中（未招募）
1 期
A study to assess the safety and efficacy of a subcutaneous formulation of efgartigimod in adults with chronic inflammatory demyelinating polyneuropathy (an autoimmune disorder that affects the peripheral nerves)MedDRA version: 20.0Level: LLTClassification code 10077384Term: Chronic inflammatory demyelinating polyneuropathySystem Organ Class: 100000004852Chronic Inflammatory Demyelinating PolyneuropathyEUCTR2019-003076-39-CZargenx BVBA400